Trials / Completed
CompletedNCT05659719
A Study to Learn About Recifercept in Patients With Achondroplasia
A Pilot Project to Evaluate the Feasibility of Constructing a Concurrent External Control for Recifercept
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 248 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 3 Months – 10 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to learn about the study medicine (called recifercept) in people with achondroplasia. Achondroplasia is a very rare disease and patients of achondroplasia have short arms and legs. The study will include data already collected from a recifercept clinical trial and data collected from a separate study of achondroplasia. This study will compare patient experiences and will help the investigators determine if the study medicine, recifercept, is effective.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Recifercept | Patients received recifercept intervention in the phase 2 clinical trial |
Timeline
- Start date
- 2022-10-19
- Primary completion
- 2023-05-16
- Completion
- 2023-05-16
- First posted
- 2022-12-21
- Last updated
- 2024-09-20
- Results posted
- 2024-09-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05659719. Inclusion in this directory is not an endorsement.